Hepatocellular carcinoma

37,811views

Hepatocellular carcinoma

oncology

oncology

Hepatocellular carcinoma
Pancreatic cancer
Gallbladder carcinoma
Gallbladder histology
Topoisomerase inhibitors
Oncogenes and tumor suppressor genes
Thrombophlebitis
General anesthetics
Skin histology
Atopic dermatitis
Seborrhoeic dermatitis
Contact dermatitis
Stevens-Johnson syndrome
Erythema multiforme
Psoriasis
Lichen planus
Pityriasis rosea
Urticaria
Hereditary angioedema
Vitiligo
Acne vulgaris
Onychomycosis
Skin cancer
Sunburn
Actinic keratosis
Wound healing
Contracting the immune response and peripheral tolerance
Lung cancer
Bone tumors
Chondrosarcoma
Osteochondroma
Platinum containing medications
Microtubule inhibitors
Ovarian germ cell tumors
Esophageal cancer
Renal cell carcinoma
Gastric cancer
Familial adenomatous polyposis
Pancreatic neuroendocrine neoplasms
Colorectal polyps
Juvenile polyposis syndrome
Peutz-Jeghers syndrome
Colorectal cancer
Benign liver tumors
Hepatocellular adenoma
Non-alcoholic fatty liver disease
Ovarian sex-cord stromal tumors
Endometrial cancer
Krukenberg tumor
Choriocarcinoma
Ovarian germ cell tumors
Endometrial cancer
Colorectal cancer
Ovarian sex-cord stromal tumors
Ovarian surface epithelial tumors
Colorectal polyps and cancer: Pathology review
Osteochondroma
Bone tumors
Acne vulgaris
Acneiform skin disorders: Pathology review
Psoriasis
Lichen planus
Atopic dermatitis
Contact dermatitis
Actinic keratosis
Pigmentation skin disorders: Pathology review
Skin cancer
Peutz-Jeghers syndrome
Juvenile polyposis syndrome
Colorectal polyps
Familial adenomatous polyposis
Esophageal cancer
Gastric cancer
Gardner syndrome
Benign liver tumors
Hepatocellular adenoma
Gallbladder carcinoma
Cholangiocarcinoma
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Malassezia (Tinea versicolor and Seborrhoeic dermatitis)
Chondrosarcoma
Cannabis use disorder
Renal cell carcinoma
Testicular cancer
Choriocarcinoma
Nasopharyngeal carcinoma
Mesothelioma
Pheochromocytoma
Adrenal cortical carcinoma
Transitional cell carcinoma
Non-urothelial bladder cancers
Thyroid cancer
Acoustic neuroma (schwannoma)
Pediatric brain tumors
Pituitary adenoma
Adult brain tumors
Retinoblastoma
Echinococcus granulosus (Hydatid disease)
Diphyllobothrium latum
Ascaris lumbricoides
Trichuris trichiura (Whipworm)
Strongyloides stercoralis
Enterobius vermicularis (Pinworm)
Toxocara canis (Visceral larva migrans)
Ancylostoma duodenale and Necator americanus
Sensitivity and specificity

Transcript

Watch video only

Content Reviewers

As opposed to benign hepatic tumors, malignant hepatic tumors are cancerous, very severe, and are actually now the third leading cause of cancer deaths worldwide.

With these malignant liver cells or hepatocytes, just like malignant cells in other cancers, they develop some mutation that causes them to replicate at way higher rates and form these masses of cells that continue to grow and potentially spread to other tissues.

This would be a primary hepatic tumor, since it starts in the liver. It’s totally possible, though, for liver tumor to develop as a metastasis from another primary cancer, in which case it would not be hepatocellular carcinoma, but a carcinoma from somewhere else, and this is actually more common than primary liver tumors themselves.

The most common sources of the tumor cells that got to the liver but started somewhere else are the colon, pancreas, lung and breast.

What exactly causes the mutation in the hepatocyte though?

Well the mechanism isn’t fully understood and can probably be caused by a lot of different things, most importantly though, things that put the liver in a constant cycle of damage and repair are the biggest culprits.

If the liver cells are constantly being forced to repair, this raises the chances of genetic mistakes or mutations, potentially leading to carcinogenesis or development of cancer cells.

Examples might be any disease that leads to cirrhosis and scarring of the liver tissue, which can include alcoholic hepatitis and cirrhosis, hereditary hemochromatosis, primary biliary cirrhosis, alpha-1 antitrypsin deficiency, and others.

The most common risk factor, the ones that have been linked the most with hepatocellular carcinoma are the hepatitis B and hepatitis C viruses, both of which can become chronic or long-lasting.

In this case, these cells are at greater risk because of the constant state of infection and immune cell attack, leading to constant damage and repair.

HBV is particularly problematic because of how the virus replicates; the HBV virus is a DNA virus that integrates into the hepatocyte’s DNA, which, although not completely understood, is thought to either directly disrupt regulation of cell growth and replication, leading to carcinoma, or alternatively cause some indirect effect that later leads to unchecked cell growth and replication.

One interesting risk factor, is exposure to aflatoxins.

Aflatoxins are highly toxic chemicals produced by certain aspergillus molds that can be found in certain foods when they start to decay, like grains, peanuts, and vegetables.

As foods that have this type of mold are eaten, aflatoxins are also eaten, and then they’re absorbed in the small intestine and sent to the liver for metabolizing.

The most potent type of aflatoxin thought to be involved in carcinogenesis is aflatoxin B1, and when it gets to the liver, it’s metabolized to aflatoxin B1 8,9 epoxide.

And now this guy can bind right to DNA, called a DNA adduct.

This interaction leads to mutations in the p53 tumor suppressor gene, which usually when it’s functioning right, stops the formation of tumors, so if it becomes mutated and dysfunctional, tumor formation and carcinogenesis might follow.

Because most patients with hepatocellular carcinoma also have cirrhosis, the hepatocellular carcinoma can be hard to spot.